Position Summary
We are seeking an Automation Scientist to contribute to the development, implementation, and optimization of innovative lab automation systems to enable robust and efficient high-quality data generation for high-throughput cell therapy manufacturing QC testing.
This hire will work closely with our Automation Engineering, Analytical Development, and Quality Control teams to capture and manage automated QC method requirements and data quality specifications. This hire will have a strong background in laboratory automation, instrumentation, and data analysis methodologies to implement assay optimization and troubleshooting strategies to streamline the transfer of benchtop assays to fully automated end-to-end workflows. This hire will also work with cross-functional teams to develop and implement assay method validation and verification test plans to ensure our systems meet requirements and quality expectations.
Candidates should enjoy working in a fast-paced, mission-driven environment and be prepared to tackle a broad selection of challenges as the company grows.
Annual Salary Range: $90,000 - $210,000
Cellares total compensation package contains competitive base salaries, highly subsidized Medical, Dental, and Vision Plans, 401(k) Matching, Free EV Charging, Onsite lunches, and Stock options. All displayed pay ranges are approximate, negotiable, and location dependent.
This is Cellares
Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century. The company is both developing and operating integrated technologies for cell therapy manufacturing to accelerate access to life-saving cell therapies. The company’s Cell Shuttle integrates all the technologies required for the entire manufacturing process in a flexible and high-throughput platform that delivers true walk-away, end-to-end automation. Cell Shuttles will be deployed in Cellares’ Smart Factories around the world to meet total patient demand for cell therapies at global scale. Partnering with Cellares enables academics, biotechs, and pharma companies to accelerate drug development and scale out manufacturing, lower process failure rates, lower manufacturing costs, and meet global patient demand.
The company is headquartered in South San Francisco, California with its commercial-scale IDMO Smart Factory in Bridgewater, New Jersey. The company is backed by world-class investors and has raised over $355 million in financing.
Leveling will be based on overall experience, education, and demonstration of knowledge throughout the interview process.